79403 Hematopoietic nuclear treatment
Also known as: bone marrow nuclear therapy, hematopoietic radiotherapy
Nuclear medicine therapeutic treatment for hematopoietic stem cell disorders using radiopharmaceutical therapy to modulate bone marrow function.
Clinical Context
Radiopharmaceutical therapy targeting hematopoietic system for treatment of certain leukemias, myeloproliferative disorders, or immunologic conditions.
RVU Breakdown
| Work RVU | 2.19 |
| Practice Expense RVU | 2.43 |
| Malpractice RVU | 0.07 |
| Total RVU | 4.69 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.